NASDAQ:SBOT - Stellar Biotechnologies Stock Price, News, & Analysis

$3.97
-0.19 (-4.57 %)
(As of 06/17/2019 03:18 AM ET)
Today's Range
$3.96
Now: $3.97
$4.4860
50-Day Range
$1.02
MA: $1.40
$5.20
52-Week Range
$0.75
Now: $3.97
$3.25
Volume88,666 shs
Average Volume2.95 million shs
Market Capitalization$21.16 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SBOT
CUSIPN/A
Phone805-488-2800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210,000.00
Book Value$2.12 per share

Profitability

Net Income$-5,030,000.00
Net Margins-1,782.64%

Miscellaneous

Employees25
Market Cap$21.16 million
Next Earnings Date8/14/2019 (Estimated)
OptionableNot Optionable

Receive SBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for SBOT and its competitors with MarketBeat's FREE daily newsletter.

Stellar Biotechnologies (NASDAQ:SBOT) Frequently Asked Questions

What is Stellar Biotechnologies' stock symbol?

Stellar Biotechnologies trades on the NASDAQ under the ticker symbol "SBOT."

When did Stellar Biotechnologies' stock split? How did Stellar Biotechnologies' stock split work?

Stellar Biotechnologies shares reverse split on the morning of Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 4th 2018. An investor that had 100 shares of Stellar Biotechnologies stock prior to the reverse split would have 14 shares after the split.

How were Stellar Biotechnologies' earnings last quarter?

Stellar Biotechnologies Inc (NASDAQ:SBOT) issued its earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analyst estimates of $0.11 million. Stellar Biotechnologies had a negative net margin of 1,782.64% and a negative return on equity of 51.12%. View Stellar Biotechnologies' Earnings History.

When is Stellar Biotechnologies' next earnings date?

Stellar Biotechnologies is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Stellar Biotechnologies.

Has Stellar Biotechnologies been receiving favorable news coverage?

Headlines about SBOT stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stellar Biotechnologies earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Stellar Biotechnologies.

Who are some of Stellar Biotechnologies' key competitors?

What other stocks do shareholders of Stellar Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Nexgen Energy (NXE), Progenics Pharmaceuticals (PGNX), Anavex Life Sciences (AVXL), Eyepoint Pharmaceuticals (EYPT), Opko Health (OPK), Rigel Pharmaceuticals (RIGL), Verastem (VSTM), XOMA (XOMA), Statoil (STO) and TransEnterix (TRXC).

Who are Stellar Biotechnologies' key executives?

Stellar Biotechnologies' management team includes the folowing people:
  • Mr. Frank R. Oakes, Chairman, Pres & CEO (Age 69)
  • Ms. Kathi Niffenegger CPA, CFO & Corp. Sec. (Age 62)
  • Mr. Gary Koppenjan, Sr. Director of Investor Relations & Communications
  • Brando Lincicum, Exec. Director of Aquaculture and Facility Operations

How do I buy shares of Stellar Biotechnologies?

Shares of SBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Stellar Biotechnologies' stock price today?

One share of SBOT stock can currently be purchased for approximately $3.97.

How big of a company is Stellar Biotechnologies?

Stellar Biotechnologies has a market capitalization of $21.16 million and generates $210,000.00 in revenue each year. The biotechnology company earns $-5,030,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis. Stellar Biotechnologies employs 25 workers across the globe.View Additional Information About Stellar Biotechnologies.

What is Stellar Biotechnologies' official website?

The official website for Stellar Biotechnologies is http://www.stellarbiotechnologies.com/.

How can I contact Stellar Biotechnologies?

Stellar Biotechnologies' mailing address is 332 EAST SCOTT STREET, PORT HUENEME CA, 93041. The biotechnology company can be reached via phone at 805-488-2800 or via email at [email protected]


MarketBeat Community Rating for Stellar Biotechnologies (NASDAQ SBOT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  175 (Vote Underperform)
Total Votes:  353
MarketBeat's community ratings are surveys of what our community members think about Stellar Biotechnologies and other stocks. Vote "Outperform" if you believe SBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel